In this issue:
KTE-X19 CAR T-cell therapy in R/R MCL
Acalabrutinib ± obinutuzumab in CLL
Effects of obesity in AML
CV toxicity in NHL treated with CHOP or R-CHOP
Lenalidomide maintenance for DLBCL
Baseline SUVmax did not predict histological transformation
Stat3 mutations and large granular lymphocyte leukaemia
Acalabrutinib in R/R CLL
Survivors of early-adolescent and young adult cancers
Avadomide in R/R DLBCL
Please login below to download this issue (PDF)